October is Cybersecurity Awareness Month. Throughout the month we will be asking our experts to help us navigate cybersecurity in healthcare. In our final week we are discussing the healthcare supply chain being a key threat to cyber attacks.
Read More
By Devin Partida – October is Breast Cancer Awareness Month – Cutting-edge wearable devices can detect early signs of cancer in minutes and alert providers in real time — all from the comfort of the patient’s home. They may permanently revolutionize breast cancer care.
By Karen Conley DNP RN – In recent years, burnout and workforce issues have dominated the headlines. As continuous news cycle about the impact: longer wait times, reduced availability of services, increased healthcare costs, fewer providers, and reduced quality of care, to name a few.
By Amy Brown – We have evolved to support people who like to figure things out for themselves. We’ve got YouTube tutorials and the internet for everything else. Plenty of B2B companies offer their clients DIY options, through customer portals and more. But in the complex healthcare world, DIY often won’t suffice.
In a recent interview with FINN Voices, Mark Van Sumeren, Health Practice General Manager for LogicSource, sheds light on the untapped potential in healthcare’s indirect nonclinical purchases and why 2024 is the year to innovate.
October is Cybersecurity Awareness Month. Throughout the month we will be asking our experts to help us navigate cybersecurity in healthcare. It’s week 3 and we are talking about the biggest buzz in healthcare – AI.
By April Miller – Burnout is a problem in many industries, but it’s particularly problematic in healthcare. In addition to being all too common, stress and burnout among clinicians can affect patient outcomes and limit hospitals’ capacity to treat people. Artificial intelligence (AI) and automation could help.
By Joe Payne – Part of our Cybersecurity Awareness Month. Few industries place as much value on their intellectual property as the life sciences sector. On average, it takes $2.3B investment and between 10 – 15 years to go to market. In 2020, the U.S. biopharmaceutical industry spent $122B on R&D.
By Susan Tyler – I recently had the privilege of attending the IDN Summit and Reverse Expo 2023. At the event, LogicSource hosted a series of focus groups titled, “Reducing Non-Clinical Costs to Improve Operating Margins and Fund Patient Care Initiatives.” Participating in these enlightening discussions provided fresh perspectives on a critical industry challenge: